The heparin market consists of heparin sales by entities (organizations, partnerships, and sole proprietors) that refer to an anticoagulant (blood thinner) medication that prevents the formation of blood clots. It is injected into a vein to treat and prevent blood clots caused by certain medical conditions or procedures. Heparin is commonly used in hospitals to prevent excessive coagulation during cardiac surgery, extracorporeal circulation, or dialysis.
Heparin Market is classified into three types: unfractionated heparin, low molecular weight heparin (LMWH), and ultra-low molecular weight heparin. The unfractionated heparin (UFH) market refers to a type of fast-acting anticoagulant medication that prevents clot formation by combining with antithrombin.
Read More @ https://cmiinfonest.blogspot.com/2022/11/heparin-market-global-industry-trends.html
